Cerenome (CNSY) FCF Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
Cerenome (CNSY) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 26,102.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 869.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 769.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 811.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 19,111.00 |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -143,907.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -143,907.00 |
| Mar 31, 2026 | -10,328.00 |
| Dec 31, 2025 | -37,520.00 |
| Sep 30, 2025 | 6,939.00 |
| Jun 30, 2025 | -32,138.00 |
| Mar 31, 2025 | -31,160.00 |
| Dec 31, 2024 | -13,483.00 |
| Sep 30, 2024 | -19,896.00 |
| Jun 30, 2024 | 5,054.00 |
| Mar 31, 2024 | 89,253.00 |
| Dec 31, 2023 | 352,180.00 |
| Sep 30, 2023 | 437,265.00 |
| Mar 31, 2019 | 10,472.00 |
| Dec 31, 2018 | 43,601.00 |
| Sep 30, 2018 | 59,038.00 |
| Jun 30, 2018 | 11,511.00 |
| Mar 31, 2018 | 24,197.00 |
| Dec 31, 2017 | -28,288.00 |
| Sep 30, 2017 | -26,969.00 |
| Jun 30, 2017 | -3,641.00 |